93. 原発性胆汁性胆管炎 Primary biliary cholangitis Clinical trials / Disease details

臨床試験数 : 298 / 薬物数 : 252 - (DrugBank : 59) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 115

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05751967 (ClinicalTrials.gov)	February 22, 2023	13/12/2022	Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis	A Prospective, Multi-center, Randomized, Double-blind, Placebo-controlled Study: Fenofibrate Combine ...	Primary Biliary Cholangitis	Drug: Placebo Combined With Ursodeoxycholic Acid;Drug: Fenofibrate Combined With Ursodeoxycholic Acid ...	Xijing Hospital of Digestive Diseases	NULL	Recruiting	18 Years	75 Years	All	150	Phase 3	China
2	NCT05749822 (ClinicalTrials.gov)	February 17, 2023	29/12/2022	Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis	Fenofibrate Combined With Ursodeoxycholic Acidin Compensated Cirrhosis Patients With Primary Biliary ...	Primary Biliary Cholangitis	Drug: Fenofibrate 200mg;Drug: Placebo;Drug: UDCA	Xijing Hospital of Digestive Diseases	NULL	Recruiting	18 Years	75 Years	All	104	Phase 2/Phase 3	China
3	NCT02965911 (ClinicalTrials.gov)	January 2016	15/11/2016	Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical ...	A Randomized Controlled Clinical Trial on the Efficacy and Safety of Fenofibrate Combined With Ursod ...	Primary Biliary Cirrhosis	Drug: Fenofibrate;Drug: UDCA	Beijing 302 Hospital	NULL	Withdrawn	18 Years	65 Years	All	0	Phase 1/Phase 2	China

First Previous1Next Last